← Back to Search

Music Therapy for Pediatric Cancer

N/A

Recruiting

Led By Sheri L Robb, PhD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Child has diagnosis of standard or high risk B- or T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LyLy)

Child is 3 - 8 years of age at time of enrollment

Must not have

The parent does not speak English

Child is taking steroid medication for asthma and/or has asthma that is not well controlled

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre/post-sessions 1, 2, 3, and 4 (each session is 7 days apart; each session has a 45 min. duration).

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at the effects of music therapy on stress and immune function in children with cancer and their parents.

Who is the study for?

This trial is for children aged 3-8 with B- or T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma, currently in induction therapy. A parent over 18 must attend all sessions. Excluded are children with Ph+ ALL, Cushing disease, certain treatment protocols, uncontrolled asthma, steroid medication for asthma, non-English speaking parents, or significant cognitive impairments.

What is being tested?

The study tests how Active Music Engagement (AME) and listening to audio storybooks affect stress hormones and immune function in young kids with cancer and their parents during ALL treatment. It's a randomized trial comparing the biological impact of these interventions.

What are the potential side effects?

Since this trial involves music play and audio storybooks as interventions rather than medications or invasive procedures, traditional side effects are not expected; however emotional responses to music therapy may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child has been diagnosed with a serious form of leukemia or lymphoma.

Select...

My child is between 3 and 8 years old.

Select...

My child is undergoing initial cancer treatment.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I, as a parent, do not speak English.

Select...

My child is on steroids for asthma or their asthma isn't well managed.

Select...

My child has Ph+ acute lymphoblastic leukemia.

Select...

My child has Cushing disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre/post-sessions 1, 2, 3, and 4 (each session is 7 days apart; each session has a 45 min. duration).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre/post-sessions 1, 2, 3, and 4 (each session is 7 days apart; each session has a 45 min. duration).

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre/post-sessions 1, 2, 3, and 4 (each session is 7 days apart; each session has a 45 min. duration). for reporting.